menu
    • menu

    Company profile for MediLink Therapeutics

    NEW Drugs in Dev.: 6
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Founded on July 08, 2020, MediLink Therapeutics is an innovative drug development company focusing on antibody-drug conjugates (ADC) and related technologies. MediLink Therapeutics was formed by experienced scientists from both small and large-molecule drug development fields. The management team has collectively put over 20 new compounds into clinical development, 3 of them are antibody-drug conjugates. The team also has a s...
    Founded on July 08, 2020, MediLink Therapeutics is an innovative drug development company focusing on antibody-drug conjugates (ADC) and related technologies. MediLink Therapeutics was formed by experienced scientists from both small and large-molecule drug development fields. The management team has collectively put over 20 new compounds into clinical development, 3 of them are antibody-drug conjugates. The team also has a strong background in corporate governance and capital operations.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    MediLink TherapeuticsChina Flag
    Country
    Country
    China
    Address
    Address
    Biobay B3-101, Industrial Park, Suzhou
    Telephone
    Telephone
    +86 051262858368
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://medilinkthera.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/mltx/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Roche Spends $570M On Another ADC Agreement With China's Medilink
    Roche Spends $570M On Another ADC Agreement With China's Medilink

    09 Jan 2026

    // BIOSPACE

    https://www.biospace.com/deals/roche-spends-570m-on-another-adc-agreement-with-chinas-medilink

    BIOSPACE
    09 Jan 2026
    Share Share
    Zai Lab & MediLink Partner For LRRC15 Antibody-Drug Conjugate
    Zai Lab & MediLink Partner For LRRC15 Antibody-Drug Conjugate

    09 Jan 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250109316500/en

    BUSINESSWIRE
    09 Jan 2025
    Share Share
    MediLink Announces Global Trial Collaboration And Supply Agreement
    MediLink Announces Global Trial Collaboration And Supply Agreement

    07 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/medilink-announces-global-clinical-trial-collaboration-and-supply-agreement-on-yl201-combination-therapy-302268140.html

    PR NEWSWIRE
    07 Oct 2024
    Share Share
    MediLink Presents YL201 Data At ESMO 2024 Showing Pan-Tumor Benefits
    MediLink Presents YL201 Data At ESMO 2024 Showing Pan-Tumor Benefits

    13 Sep 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/medilink-presents-yl201-b7h3-adc-at-esmo-2024-with-over-6-months-pfs-in-sclc-and-showing-pan-tumor-benefits-302247652.html

    PR NEWSWIRE
    13 Sep 2024
    Share Share
    FDA allows BioNTech-MediLink ADC trial to resume with lower, safer doses
    FDA allows BioNTech-MediLink ADC trial to resume with lower, safer doses

    19 Aug 2024

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/fda-allows-biontech-medilink-adc-trial-resume-lower-doses

    FIERCE BIOTECH
    19 Aug 2024
    Share Share
    BioNTech doubles down on ADC partner MediLink in new $1.8B biobucks pact
    BioNTech doubles down on ADC partner MediLink in new $1.8B biobucks pact

    28 May 2024

    // ENDPTS

    https://endpts.com/biontech-doubles-down-on-adc-partner-medilink-in-new-1-8b-biobucks-pact/

    ENDPTS
    28 May 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search